Haemorheological predictors of cognitive decline: The Edinburgh Artery Study

Age and Ageing

Volumn 39, Issue 2, 2010, Pages 217-222

  Rafnsson, Snorri ^a   Deary, Ian J ^a   Whiteman, Martha C ^a   Rumley, Ann ^b   Lowe, G D O ^c   Fowkes, F Gerry R ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

Aged; Bloodviscosity; Cognition; Elderly; Haematocrit; Haemorheology

Indexed keywords

FIBRINOGEN;

AGED; ARTICLE; BLOOD RHEOLOGY; BLOOD VISCOSITY; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DECLARATIVE MEMORY; FEMALE; FOLLOW UP; HEMATOCRIT; HUMAN; MALE; PREDICTION; PRIORITY JOURNAL; SCORING SYSTEM; SPEECH; VARIANCE; VERBAL MEMORY;

AGED; AGING; BLOOD VISCOSITY; COGNITION DISORDERS; ENGLAND; FEMALE; FIBRINOGEN; FOLLOW-UP STUDIES; GERIATRIC ASSESSMENT; HEMATOCRIT; HEMORHEOLOGY; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS;

EID: 77949384621     PISSN: 00020729     EISSN: 14682834     Source Type: Journal    
DOI: 10.1093/ageing/afp227     Document Type: Article

References (27)

1. Neale R, Brayne C, Johnson AL. Cognition and survival: an exploration in a large multicentre study of the population aged 65 years and over. Int J Epidemiol 2001; 30: 1383-8.
2. Gorelick PB. Risk factors for vascular dementia and Alzheimer disease. Stroke 2004; 35: 2620-2.
3. Román GC. Stroke, cognitive decline and vascular dementia: the silent epidemic of the 21st century. Neuroepidemiology 2003; 22: 161-4.
4. Rafnsson SB, Deary IJ, Smith FB, Whiteman MC, Fowkes FGR. Cardiovascular diseases and decline in cognitive function in an elderly community population: the Edinburgh Artery Study. Psychosom Med 2007; 69: 425-34.
5. Mathiesen EB, Joakimsen O, Bønaa KH. Prevalence of and risk factors associated with carotid artery stenosis: the Tromsø Study. Cerebrovasc Dis 2001; 12: 44-51.
6. Russell D. Cerebral microemboli and cognitive impairment. J Neurol Sci 2002; 203-204: 211-4.
7. Molloy J, Markus HS. Asymptomatic embolization predicts stroke and TIA in patients with carotid artery stenosis. Stroke 1999; 30: 1440-3.
8. Pullicino PM, Hart J. Cognitive impairment in congestive heart failure?: embolism vs hypoperfusion. Neurology 2001; 57: 1945-6.
9. Lowe GDO. Rheological influences on thombosis. Bailliere's Clin Haematol 1994; 7: 573-90.
10. Lee AJ, Mowbray PI, Lowe GDO, Rumely A, Fowkes FG, Allan PL. Blood viscosity and elevated carotid intima-media thickness in men and women. The Edinburgh Artery Study. Circulation 1998; 97: 1467-73.
11. Lowe GDO, Lee AJ, Rumley A, Price JF, Fowkes FG. Blood viscosity and risk of cardiovascular events: the Edinburgh Artery Study. Br J Haematol 1997; 96: 168-73.
12. Ajmani RS, Metter EJ, Jaykumar R et al. Hemodynamic changes during aging associated with cerebral blood flow and impaired cognitive function. Neurobiol Aging 2000; 21: 257-69.
13. Elwood PC, Pickering J, Gallacher JEJ. Cognitive function and blood rheology: results from the Caerphilly cohort of older men. Age Ageing 2001; 30: 135-9.
14. Kee DB, Wood JH. Rheology of the cerebral circulation. Neurosurgery 1984; 15: 125-31.
15. Lowe GDO. Is sticky blood a treatable determinant of cognitive decline and of dementia? Age Ageing 2001; 30: 101-3.
16. Campbell DT, Kenny DA. A Primer on Regression Artefacts. New York: Guilford Press, 1999.
17. Deary IJ, Whalley LJ, Crawford JR. An 'instantaneous' estimate of a lifetime's cognitive change. Intelligence 2004; 32: 113-9.
18. Xu G, Zhang H, Zhang S, Fan X, Liu X. Plasma fibrinogen is associated with cognitive decline and risk for dementia in patients with mild cognitive impairment. Int J Clin Pract 2007, doi: 10.1111/j.1742-1241.2007.01268.x.
19. Rumley A, Scott DJ, Lowe GDO, Murray H, Westendrop RGJ. Plasma fibrinogen and viscosity and risk of cognitive decline in elderly patients with vascular risk factors or disease. J Thromb Haemostas 2005; 3: P0680.
20. Danesh J, Collins R, Peto R, Lowe GD. Haematocrit, viscosity, erythrocyte sedimentation rate: meta-analyses of prospective studies of coronary heart disease. Eur Heart J 2000; 21: 515-20.
21. Tzoulaki I, Murray GD, Lee AJ, Rumley A, Lowe GD, Fowkes FG. Relative value of inflammatory, hemostatic and rheological factors for incident myocardial infarction and stroke. The Edinburgh Artery Study. Circulation 2007; 115: 2119-27.
22. Price JF, McDowell S, Whiteman MC, Deary IJ, Stewart MC, Fowkes FGR. Ankle brachial index as a predictor of cognitive impairment in the general population: ten-year follow-up of the Edinburgh Artery Study. J Am Geriatr Soc 2006; 54: 763-9.
23. Fibrinogen Studies CollaborationPlasma fibrinogen level and the risk of major cardiovascular diseases and non-vascular mortality: an individual participant meta-analysis. J Am Med Assoc 2005; 294: 1799-809.
24. Bots ML, Elwood PC, Salonen JT et al. Level of fibrinogen and risk of fatal and non-fatal stroke. EUROSTROKE: a collaborative study among research centres in Europe. J Epidemiol Community Health 2002; 56: 14-8.
25. Knuiman MW, Folsom AR, Chambless LE, Liao D, Wu KK. Association of hemostatic variables with MRI-detected cerebral abnormalities: the Atherosclerosis Risk in Communities Study. Neuroepidemiology 2001; 20: 96-104.
26. Schneider JA, Wilson RS, Cochran EJ et al. Relation of cerebral infarctions to dementia and cognitive function in older persons. Neurology 2003; 60: 1082-8.
27. Laurin D, Masaki KH, White LR, Launer LJ. Ankle-to-brachial index and dementia: the Honolulu-Asia Aging Study. Circulation 2007, doi: 10.1161/CIRCULATIONAHA.106.686477.